334 related articles for article (PubMed ID: 28109960)
1. RNA Nanoparticle-Based Targeted Therapy for Glioblastoma through Inhibition of Oncogenic miR-21.
Lee TJ; Yoo JY; Shu D; Li H; Zhang J; Yu JG; Jaime-Ramirez AC; Acunzo M; Romano G; Cui R; Sun HL; Luo Z; Old M; Kaur B; Guo P; Croce CM
Mol Ther; 2017 Jul; 25(7):1544-1555. PubMed ID: 28109960
[TBL] [Abstract][Full Text] [Related]
2. RNA nanoparticle as a vector for targeted siRNA delivery into glioblastoma mouse model.
Lee TJ; Haque F; Shu D; Yoo JY; Li H; Yokel RA; Horbinski C; Kim TH; Kim SH; Kwon CH; Nakano I; Kaur B; Guo P; Croce CM
Oncotarget; 2015 Jun; 6(17):14766-76. PubMed ID: 25885522
[TBL] [Abstract][Full Text] [Related]
3. Delivery of Anti-miRNA for Triple-Negative Breast Cancer Therapy Using RNA Nanoparticles Targeting Stem Cell Marker CD133.
Yin H; Xiong G; Guo S; Xu C; Xu R; Guo P; Shu D
Mol Ther; 2019 Jul; 27(7):1252-1261. PubMed ID: 31085078
[TBL] [Abstract][Full Text] [Related]
4. RNA Nanoparticles Derived from Three-Way Junction of Phi29 Motor pRNA Are Resistant to I-125 and Cs-131 Radiation.
Li H; Rychahou PG; Cui Z; Pi F; Evers BM; Shu D; Guo P; Luo W
Nucleic Acid Ther; 2015 Aug; 25(4):188-97. PubMed ID: 26017686
[TBL] [Abstract][Full Text] [Related]
5. Non-Specific Blocking of miR-17-5p Guide Strand in Triple Negative Breast Cancer Cells by Amplifying Passenger Strand Activity.
Jin YY; Andrade J; Wickstrom E
PLoS One; 2015; 10(12):e0142574. PubMed ID: 26629823
[TBL] [Abstract][Full Text] [Related]
6. MiRNA-21 silencing mediated by tumor-targeted nanoparticles combined with sunitinib: A new multimodal gene therapy approach for glioblastoma.
Costa PM; Cardoso AL; Custódia C; Cunha P; Pereira de Almeida L; Pedroso de Lima MC
J Control Release; 2015 Jun; 207():31-9. PubMed ID: 25861727
[TBL] [Abstract][Full Text] [Related]
7. Targeting strategies on miRNA-21 and PDCD4 for glioblastoma.
Wang G; Wang JJ; Tang HM; To SS
Arch Biochem Biophys; 2015 Aug; 580():64-74. PubMed ID: 26142886
[TBL] [Abstract][Full Text] [Related]
8. Role of miR-21 in the growth and metastasis of human salivary adenoid cystic carcinoma.
Yan F; Wang C; Li T; Cai W; Sun J
Mol Med Rep; 2018 Mar; 17(3):4237-4244. PubMed ID: 29328455
[TBL] [Abstract][Full Text] [Related]
9. Efficient delivery of anti-miR-210 using Tachyplesin, a cell penetrating peptide, for glioblastoma treatment.
Jana A; Narula P; Chugh A; Kulshreshtha R
Int J Pharm; 2019 Dec; 572():118789. PubMed ID: 31726199
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of Pdcd4 by mir-21 facilitates glioblastoma proliferation in vivo.
Gaur AB; Holbeck SL; Colburn NH; Israel MA
Neuro Oncol; 2011 Jun; 13(6):580-90. PubMed ID: 21636706
[TBL] [Abstract][Full Text] [Related]
11. Anti-cancer effect of R3V6 peptide-mediated delivery of an anti-microRNA-21 antisense-oligodeoxynucleotide in a glioblastoma animal model.
Oh B; Song H; Lee D; Oh J; Kim G; Ihm SH; Lee M
J Drug Target; 2017 Feb; 25(2):132-139. PubMed ID: 27355932
[TBL] [Abstract][Full Text] [Related]
12. Modulation of miR-21 signaling by MPS1 in human glioblastoma.
Maachani UB; Tandle A; Shankavaram U; Kramp T; Camphausen K
Oncotarget; 2016 Aug; 7(33):52912-52927. PubMed ID: 25991676
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-21 silencing enhances the cytotoxic effect of the antiangiogenic drug sunitinib in glioblastoma.
Costa PM; Cardoso AL; Nóbrega C; Pereira de Almeida LF; Bruce JN; Canoll P; Pedroso de Lima MC
Hum Mol Genet; 2013 Mar; 22(5):904-18. PubMed ID: 23201752
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of miR-21 by 3'/5'-Serinyl-Capped 2'-O-Methyl RNA Interspersed with 2'-O-(2-Amino-3-Methoxypropyl) Uridine Units.
Nahar S; Kotikam V; Kumar VA; Maiti S
Nucleic Acid Ther; 2016 Oct; 26(5):327-334. PubMed ID: 27454558
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-21 down-regulates the expression of tumor suppressor PDCD4 in human glioblastoma cell T98G.
Chen Y; Liu W; Chao T; Zhang Y; Yan X; Gong Y; Qiang B; Yuan J; Sun M; Peng X
Cancer Lett; 2008 Dec; 272(2):197-205. PubMed ID: 19013014
[TBL] [Abstract][Full Text] [Related]
16. MiR-21 overexpression is associated with acquired resistance of EGFR-TKI in non-small cell lung cancer.
Li B; Ren S; Li X; Wang Y; Garfield D; Zhou S; Chen X; Su C; Chen M; Kuang P; Gao G; He Y; Fan L; Fei K; Zhou C; Schmit-Bindert G
Lung Cancer; 2014 Feb; 83(2):146-53. PubMed ID: 24331411
[TBL] [Abstract][Full Text] [Related]
17. Assessment and comparison of thermal stability of phosphorothioate-DNA, DNA, RNA, 2'-F RNA, and LNA in the context of Phi29 pRNA 3WJ.
Piao X; Wang H; Binzel DW; Guo P
RNA; 2018 Jan; 24(1):67-76. PubMed ID: 29051199
[TBL] [Abstract][Full Text] [Related]
18. Convection-enhanced delivery of an anti-miR is well-tolerated, preserves anti-miR stability and causes efficient target de-repression: a proof of concept.
Halle B; Marcusson EG; Aaberg-Jessen C; Jensen SS; Meyer M; Schulz MK; Andersen C; Kristensen BW
J Neurooncol; 2016 Jan; 126(1):47-55. PubMed ID: 26428358
[TBL] [Abstract][Full Text] [Related]
19. The Cancer Genome Atlas Analysis Predicts MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma.
Wong HA; Fatimy RE; Onodera C; Wei Z; Yi M; Mohan A; Gowrisankaran S; Karmali P; Marcusson E; Wakimoto H; Stephens R; Uhlmann EJ; Song JS; Tannous B; Krichevsky AM
Mol Ther; 2015 Jul; 23(7):1234-1247. PubMed ID: 25903473
[TBL] [Abstract][Full Text] [Related]
20. Ars2 is overexpressed in human cholangiocarcinomas and its depletion increases PTEN and PDCD4 by decreasing microRNA-21.
He Q; Cai L; Shuai L; Li D; Wang C; Liu Y; Li X; Li Z; Wang S
Mol Carcinog; 2013 Apr; 52(4):286-96. PubMed ID: 22213145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
